OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ADAG

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Adagene (ADAG) Earnings Date & Reports

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADAG is expected to report earnings to fall 21.74% to -18 cents per share on December 03

Q3'25

Est.

$-0.18

Q2'25

Beat

by $0.10

Q4'24

Beat

by $0.18

Q2'24

Missed

by $0.03

Q4'23

Beat

by $0.96

The last earnings report on August 12 showed earnings per share of -23 cents, beating the estimate of -33 cents. With 33.38K shares outstanding, the current market capitalization sits at 111.70M.

View a ticker or compare two or three

Compare

ADAG

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ADAG
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADAG showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Xinghu Street, Suzhou Industrial Park

Phone

+86 51287773632

Employees

174

Web

https://www.adagene.com